Tag: avita medical

October 5, 2016

FDA Approves Continued Access to ReCell(R) in US Burns Trial

The US Food and Drug Administration has approved Continued Access to ReCell, allowing US burns surgeons participating in Avita Medical's...
September 23, 2016

Avita Medical to Hold ReCell(R) Symposium at Burns Association Course

Avita Medical, a regenerative medicine company specializing in new treatments for wounds and skin defects, said today it will host...
March 9, 2016

Avita Medical Reports Positive Results from Randomized, Multicentre EU Study of ReGenerCell™

Avita Medical Ltd, (ASX: AVH, OTCQX: AVMXY) reported positive results from the Company's multicentre clinical trial of ReGenerCell™ in the...
February 5, 2016

Avita Medical Completes Sale of Respiratory Business for $2.47 Million

Avita Medical Limited (ASX:AVH, OTCQX:AVMXY), a regenerative medicine company specializing in the treatment of wounds and skin defects, has completed...
July 20, 2015

Avita Medica's ReCell Technology To Be Used By U.S. Department of Defense

Avita Medical (ASX:AVH) announces that the U.S. Department of Defense would like to use its innovative ReCell technology burn treatment.